Internal Medicine, Rheumatology · Westlake, OH
NPI
1871741967
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
25200 Center Ridge Rd Ste 2100
Westlake, OH, 44145
Phone (440) 331-5962
Groups this clinician bills Medicare through
Medicare paid, 2024
$738K
73,974 services
Medicare patients, 2024
395
Average age 75
Drug cost, 2024
$7.4M
7,528 prescriptions
Company payments, 2025
$36K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bassam Haddad was code J1602 (injection, golimumab, 1 mg, for intravenous use), 14,950 times for 21 patients. In total Bassam Haddad billed 73,974 services in 107 codes, and Medicare paid $738K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 14,950 | 21 | $8.65 | $129K |
| J0897 Injection, denosumab, 1 mg | Office | 5,400 | 54 | $20.50 | $111K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 492 | 75 | $0.75 | $369 |
| 99214 Office E&M - Established | Office | 410 | 234 | $82.14 | $34K |
| 99213 Office E&M - Established | Office | 208 | 136 | $59.10 | $12K |
| 80053 Clinical Chemistry | Office | 194 | 125 | $10.27 | $1,992 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 192 | 36 | $0.52 | $99.4 |
| 85025 Blood Count | Office | 190 | 123 | $7.55 | $1,434 |
| 96372 Injection Administration | Office | 182 | 62 | $10.52 | $1,915 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 174 | 130 | $11.85 | $2,062 |
| 86140 Clinical Chemistry | Office | 156 | 121 | $5.05 | $789 |
| 36415 Venipuncture Blood Collection | Office | 153 | 114 | $8.60 | $1,317 |
| 85652 Clinical Chemistry | Office | 148 | 112 | $2.64 | $390 |
| 96365 Intravenous Infusion, Hydration | Office | 121 | 27 | $44.98 | $5,443 |
| 96413 Chemotherapy Administration | Office | 93 | 14 | $92.89 | $8,639 |
By year: 2022 $593K for 52,205 services; 2023 $765K for 67,632 services; 2024 $738K for 73,974 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 194 | 125 | $10.27 | $1,992 |
| 85025 Blood Count | 190 | 123 | $7.55 | $1,434 |
| 86140 Clinical Chemistry | 156 | 121 | $5.05 | $789 |
| 36415 Venipuncture Blood Collection | 153 | 114 | $8.60 | $1,317 |
| 85652 Clinical Chemistry | 148 | 112 | $2.64 | $390 |
| 86200 Immunoassay | 42 | 42 | $12.46 | $523 |
| 86430 Immunoassay | 35 | 35 | $6.02 | $211 |
| 86038 Immunoassay | 32 | 32 | $11.85 | $379 |
| 84550 Clinical Chemistry | 29 | 24 | $4.43 | $128 |
| 82306 Clinical Chemistry | 28 | 27 | $29.01 | $812 |
Medicare prescription drug claims, 2024
In 2024, the drug Bassam Haddad prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,478 prescriptions and refills. In total Bassam Haddad wrote 7,528 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,478 | 3,276 | 411 | $66K |
| Methotrexate Methotrexate Sodium | 909 | 2,094 | 265 | $27K |
| Prednisone Generic | 483 | 716 | 228 | $2,718 |
| Gabapentin Generic | 422 | 774 | 120 | $6,633 |
| Tramadol Hcl Generic | 370 | 370 | 64 | $3,738 |
| Sulfasalazine Generic | 315 | 588 | 83 | $7,516 |
| Leflunomide Generic | 314 | 638 | 97 | $24K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 261 | 261 | 35 | $4,391 |
| Pregabalin Generic | 189 | 293 | 45 | $5,079 |
| Humira(Cf) Pen Adalimumab | 172 | 189 | 22 | $1.4M |
| Folic Acid Generic | 171 | 472 | 56 | $1,347 |
| Rinvoq Upadacitinib | 159 | 177 | 21 | $1.2M |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 150 | 150 | 20 | $4,173 |
| Alendronate Sodium Generic | 148 | 399 | 51 | $1,189 |
| Allopurinol Generic | 125 | 275 | 40 | $1,172 |
Brand drugs: - claims; generic drugs: 6,199 claims; opioid claims: 842.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bassam Haddad $36K ($36K in general payments such as food, travel and fees) from 26 companies. The largest payer was Abbvie Inc. with $25K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 69 | $25K |
| Lilly USA, LLC LLY | 6 | $3,431 |
| Janssen Biotech, Inc. JNJ | 25 | $3,006 |
| Amgen Inc. AMGN | 56 | $833 |
| AstraZeneca Pharmaceuticals LP AZN | 22 | $620 |
| Pfizer Inc. PFE | 21 | $446 |
| UCB, Inc. UCB.BR | 18 | $390 |
| Novartis Pharmaceuticals Corporation NVS | 23 | $318 |
| E.R. Squibb & Sons, L.L.C. BMY | 27 | $284 |
| ANI Pharmaceuticals, Inc. ANIP | 16 | $194 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.